Bath & Body Works Inc. (BBWI) financial statements: income statement, balance sheet and cash flow

Bath & Body Works Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Jan 31, 2026 · FY), Bath & Body Works Inc. reported revenue of $7.3B (-0.2% year on year) and net income of $649.0M (-18.7% year on year).

Income statement

Bath & Body Works Inc. income statement, fiscal years

Line item	Jan 31, 2026 · FY	Feb 1, 2025 · FY	Feb 3, 2024 · FY	Jan 28, 2023 · FY
Net Sales	$7.3B	$7.3B	$7.4B	$7.6B
Costs of Goods Sold, Buying and Occupancy	($4.1B)	($4.1B)	($4.2B)	($4.3B)
Gross Profit	$3.2B	$3.2B	$3.2B	$3.3B
General, Administrative and Store Operating Expenses	($2.1B)	($2.0B)	($2.0B)	($1.9B)
Operating Income	$1.1B	$1.3B	$1.3B	$1.4B
Interest Expense	($276.0M)	($312.0M)	($345.0M)	($348.0M)
Other Income, Net	$32.0M	$74.0M	$81.0M	$17.0M
Income Before Income Taxes	$882.0M	$1.0B	$1.0B	$1.0B
Provision for Income Taxes	($233.0M)	$230.0M	$143.0M	$251.0M
Net Income	$649.0M	$798.0M	$878.0M	$800.0M
Net Income Per Basic Share (in USD per share)	$3.12	$3.62	$3.86	$3.45
Net Income Per Diluted Share (in USD per share)	$3.11	$3.61	$3.84	$3.43

Bath & Body Works Inc. income statement, quarters

Line item	Aug 1, 2026 · Q3	May 2, 2026 · Q2	Nov 1, 2025 · Q4	Aug 2, 2025 · Q3
Net Sales	$1.5B	$1.4B	$1.6B	$1.5B
Costs of Goods Sold, Buying and Occupancy	($822.0M)	($791.0M)	($936.0M)	($909.0M)
Gross Profit	$692.0M	$587.0M	$658.0M	$640.0M
General, Administrative and Store Operating Expenses	($476.0M)	($356.0M)	($497.0M)	($483.0M)
Operating Income	$216.0M	$231.0M	$161.0M	$157.0M
Interest Expense	($63.0M)	($69.0M)	($68.0M)	($68.0M)
Other Income, Net	$11.0M	$4.0M	$10.0M	$6.0M
Income Before Income Taxes	$164.0M	$166.0M	$103.0M	$95.0M
Provision for Income Taxes	($46.0M)	$17.0M	($26.0M)	($31.0M)
Net Income	$118.0M	$183.0M	$77.0M	$64.0M
Net Income per Basic Share (in dollars per share)	$0.59	$0.91	$0.38	$0.31
Net Income per Dilutive Share (in dollars per share)	$0.58	$0.90	$0.37	$0.30

Balance sheet

Bath & Body Works Inc. balance sheet, fiscal years

Line item	Jan 31, 2026 · FY	Feb 1, 2025 · FY	Feb 3, 2024 · FY	Jan 28, 2023 · FY
Cash and Cash Equivalents	$953.0M	$674.0M	$1.1B	$1.2B
Accounts Receivable, Net	$180.0M	$205.0M	$224.0M	$226.0M
Inventories	$699.0M	$734.0M	$710.0M	$709.0M
Easton Assets Held for Sale	$81.0M	$96.0M	—	—
Other	$106.0M	$114.0M	$97.0M	$99.0M
Total Current Assets	$2.0B	$1.8B	$2.1B	$2.3B
Property and Equipment, Net	$1.1B	$1.1B	$1.2B	$1.2B
Operating Lease Assets	$941.0M	$949.0M	$1.1B	$1.1B
Goodwill	$628.0M	$628.0M	$628.0M	$628.0M
Trade Name	$165.0M	$165.0M	$165.0M	$165.0M
Deferred Income Taxes	$112.0M	$130.0M	$144.0M	$37.0M
Other Assets	$77.0M	$50.0M	$135.0M	$155.0M
Total Assets	$5.1B	$4.9B	$5.5B	$5.5B
Accounts Payable	$465.0M	$338.0M	$380.0M	$455.0M
Accrued Expenses and Other	$579.0M	$584.0M	$608.0M	$673.0M
Current Debt	$280.0M	—	—	—
Current Operating Lease Liabilities	$195.0M	$192.0M	$181.0M	$177.0M
Income Taxes	$72.0M	$117.0M	$120.0M	$74.0M
Total Current Liabilities	$1.6B	$1.2B	$1.3B	$1.4B
Deferred Income Taxes	$65.0M	$24.0M	$147.0M	$168.0M
Long-term Debt	$3.6B	$3.9B	$4.4B	$4.9B
Long-term Operating Lease Liabilities	$867.0M	$883.0M	$1.0B	$1.0B
Other Long-term Liabilities	$213.0M	$233.0M	$261.0M	$276.0M
Preferred Stock—$1.00 par value; 10 shares authorized; none issued	0	0	0	0
Common Stock—$0.50 par value; 1,000 shares authorized; 216 and 231 shares issued; 201 and 216 shares outstanding, respectively	108.0M	115.0M	120.0M	122.0M
Paid-in Capital	$794.0M	$829.0M	$838.0M	$817.0M
Accumulated Other Comprehensive Income	$74.0M	$71.0M	$75.0M	$78.0M
Retained Earnings (Accumulated Deficit)	($1.4B)	($1.6B)	($1.8B)	($2.4B)
Less: Treasury Stock, at Average Cost; 15 and 15 shares, respectively	-822.0M	-822.0M	-822.0M	-822.0M
Total Shareholders’ Equity (Deficit)	($1.3B)	($1.4B)	($1.6B)	($2.2B)
Noncontrolling Interest	$2.0M	$2.0M	$1.0M	$1.0M
Total Equity (Deficit)	($1.3B)	($1.4B)	($1.6B)	($2.2B)
Total Liabilities and Equity (Deficit)	$5.1B	$4.9B	$5.5B	$5.5B

Bath & Body Works Inc. balance sheet, quarters

Line item	Aug 1, 2026	May 2, 2026	Nov 1, 2025	Aug 2, 2025
Cash and Cash Equivalents	$794.0M	$820.0M	$236.0M	$364.0M
Accounts Receivable, Net	$154.0M	$98.0M	$169.0M	$131.0M
Inventories	$883.0M	$782.0M	$1.3B	$977.0M
Easton Assets Held for Sale	$81.0M	$81.0M	$81.0M	$81.0M
Other	$138.0M	$118.0M	$144.0M	$153.0M
Total Current Assets	$2.0B	$1.9B	$1.9B	$1.7B
Property and Equipment, Net	$1.1B	$1.1B	$1.1B	$1.1B
Operating Lease Assets	$1.0B	$974.0M	$967.0M	$984.0M
Goodwill	$628.0M	$628.0M	$628.0M	$628.0M
Trade Name	$165.0M	$165.0M	$165.0M	$165.0M
Deferred Income Taxes	$108.0M	$110.0M	$132.0M	$133.0M
Other Assets	$87.0M	$81.0M	$74.0M	$74.0M
Total Assets	$5.2B	$5.0B	$5.0B	$4.8B
Accounts Payable	$676.0M	$557.0M	$781.0M	$567.0M
Accrued Expenses and Other	$556.0M	$513.0M	$558.0M	$541.0M
Current Debt	$248.0M	$0	$0	$0
Current Operating Lease Liabilities	$199.0M	$206.0M	$193.0M	$194.0M
Income Taxes	$28.0M	$101.0M	$21.0M	$1.0M
Total Current Liabilities	$1.7B	$1.4B	$1.6B	$1.3B
Deferred Income Taxes	$115.0M	$115.0M	$23.0M	$23.0M
Long-term Debt	$3.4B	$3.6B	$3.9B	$3.9B
Long-term Operating Lease Liabilities	$931.0M	$894.0M	$897.0M	$912.0M
Other Long-term Liabilities	$91.0M	$95.0M	$218.0M	$235.0M
Preferred Stock - $1.00 par value; 10 shares authorized; none issued	0	0	0	0
Common Stock - $0.50 par value; 1,000 shares authorized; 217, 216 and 223 shares issued; 202, 201 and 208 shares outstanding, respectively	108.0M	108.0M	109.0M	111.0M
Paid-in Capital	$799.0M	$799.0M	$801.0M	$806.0M
Accumulated Other Comprehensive Income	$73.0M	$74.0M	$73.0M	$73.0M
Retained Earnings (Accumulated Deficit)	($1.2B)	($1.3B)	($1.8B)	($1.7B)
Less: Treasury Stock, at Average Cost; 15, 15 and 15 shares, respectively	-822.0M	-822.0M	-822.0M	-822.0M
Total Shareholders’ Equity (Deficit)	($1.1B)	($1.1B)	($1.6B)	($1.5B)
Noncontrolling Interest	$2.0M	$2.0M	$1.0M	$1.0M
Total Equity (Deficit)	($1.1B)	($1.1B)	($1.6B)	($1.5B)
Total Liabilities and Equity (Deficit)	$5.2B	$5.0B	$5.0B	$4.8B

Cash flow statement

Bath & Body Works Inc. cash flow statement, fiscal years

Line item	Jan 31, 2026 · FY	Feb 1, 2025 · FY	Feb 3, 2024 · FY	Jan 28, 2023 · FY
Net Income	$649.0M	$798.0M	$878.0M	$800.0M
Depreciation of Long-lived Assets	$254.0M	$282.0M	$269.0M	$221.0M
Share-based Compensation Expense	$31.0M	$40.0M	$43.0M	$38.0M
Gain on Sale of Non-core Asset	($8.0M)	—	—	—
Gain on Sales of Easton Investments	$0	($39.0M)	—	—
Loss on extinguishment of debt	$0	$10.0M	($34.0M)	$0
Deferred Income Taxes	$63.0M	($112.0M)	($128.0M)	$17.0M
Impairment of Equity Method Investment	$0	$0	$8.0M	—
Accounts Receivable	$25.0M	$18.0M	$2.0M	$11.0M
Inventories	$37.0M	($26.0M)	($2.0M)	$0
Accounts Payable, Accrued Expenses and Other	$111.0M	($50.0M)	($109.0M)	$44.0M
Income Taxes Payable	($57.0M)	($23.0M)	$34.0M	$39.0M
Other Assets and Liabilities	($3.0M)	($12.0M)	($7.0M)	($26.0M)
Net Cash Provided by Operating Activities	$1.1B	$886.0M	$954.0M	$1.1B
Capital Expenditures	($237.0M)	($226.0M)	($298.0M)	($328.0M)
Proceeds from Sale of Non-core Asset	$9.0M	—	—	—
Proceeds from Sales of Easton Investments, Net of Fees Paid	$0	$40.0M	—	—
Other Investing Activities	$1.0M	$24.0M	$12.0M	$0
Net Cash Used for Investing Activities	($227.0M)	($162.0M)	($286.0M)	($328.0M)
Payments for Long-term Debt	$0	($522.0M)	($447.0M)	$0
Repurchases of Common Stock	($401.0M)	($401.0M)	($148.0M)	($1.3B)
Dividends Paid	($167.0M)	($177.0M)	($182.0M)	($186.0M)
Payments of Finance Lease Obligations	($14.0M)	($17.0M)	($15.0M)	($9.0M)
Tax Payments related to Share-based Awards	($8.0M)	($16.0M)	($11.0M)	($32.0M)
Other Financing Activities	($9.0M)	$3.0M	($13.0M)	($4.0M)
Net Cash Used for Financing Activities	($599.0M)	($1.1B)	($815.0M)	($1.6B)
Effects of Exchange Rate Changes on Cash and Cash Equivalents	$3.0M	($2.0M)	($1.0M)	($1.0M)
Net Increase (Decrease) in Cash and Cash Equivalents	$279.0M	($410.0M)	($148.0M)	($747.0M)
Cash and Cash Equivalents, Beginning of Year	$674.0M	$1.1B	$1.2B	$2.0B
Cash and Cash Equivalents, End of Year	$953.0M	$674.0M	$1.1B	$1.2B

Bath & Body Works Inc. cash flow statement, quarters

Line item	Aug 1, 2026 · YTD	May 2, 2026 · Q2	Nov 1, 2025 · YTD	Aug 2, 2025 · YTD
Net Income	$301.0M	$183.0M	$246.0M	$169.0M
Depreciation of Long-lived Assets	$120.0M	$61.0M	$191.0M	$128.0M
Share-based Compensation Expense	$10.0M	$8.0M	$25.0M	$18.0M
Loss on Extinguishment of Debt	$8.0M	$8.0M	—	—
Tax Benefit from Resolution of Certain Tax Matters	($62.0M)	($62.0M)	—	—
Accounts Receivable	$26.0M	$82.0M	$36.0M	$75.0M
Inventories	($185.0M)	($83.0M)	($516.0M)	($241.0M)
Accounts Payable, Accrued Expenses and Other	$191.0M	$34.0M	$390.0M	$157.0M
Income Taxes Payable	($56.0M)	$29.0M	($124.0M)	($139.0M)
Other Assets and Liabilities	($37.0M)	($13.0M)	($14.0M)	($21.0M)
Net Cash Provided by Operating Activities	$316.0M	$244.0M	$225.0M	$145.0M
Capital Expenditures	($98.0M)	($49.0M)	($174.0M)	($93.0M)
Proceeds from Sale of Non-core Asset	$8.0M	$8.0M	$9.0M	—
Other Investing Activities	$1.0M	($1.0M)	($2.0M)	($2.0M)
Net Cash Used for Investing Activities	($89.0M)	($42.0M)	($167.0M)	($95.0M)
Payments for Long-term Debt	($289.0M)	($289.0M)	$0	$0
Repurchases of Common Stock	$0	$0	($344.0M)	($254.0M)
Dividends Paid	($80.0M)	($40.0M)	($126.0M)	($85.0M)
Other Financing Activities	($15.0M)	($3.0M)	($8.0M)	($15.0M)
Net Cash Used for Financing Activities	($384.0M)	($335.0M)	($497.0M)	($362.0M)
Effects of Exchange Rate Changes on Cash and Cash Equivalents	($2.0M)	$0	$1.0M	$2.0M
Net Decrease in Cash and Cash Equivalents	($159.0M)	($133.0M)	($438.0M)	($310.0M)
Cash and Cash Equivalents, Beginning of Year	$953.0M	$953.0M	$674.0M	$674.0M
Cash and Cash Equivalents, End of Period	$794.0M	$820.0M	$236.0M	$364.0M

Bath & Body Works Inc. score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.